Pathology | Cohort1 MS | Cohort2 | Cohort3 CD | Control group | |||
---|---|---|---|---|---|---|---|
PsA | RA | AS | CIRDs | ||||
Female / Male | 10 / 11* | 5 / 6 | 8 / 0 | 2 / 1 | 15 / 7 | 8 / 10 | 10 / 9 |
JCPyV+ / JCPyV- | 2 / 18* | 4 / 7 | 7 /1 | 3 / 0 | 14 / 8 | 6 / 12 | 5 / 14 |
JCPyV load†| 3.90 (3.70 - 4.10) | 7.27 (4.23-8.09) | 6.92 (4.15-8.13) | 7.25 (5.08-7.68) | 7.21 (4.15 - 8.13) | 6.30 (4.85-8.85) | 5.75 (3.54-8.43) |
Age†| 37 (19–49) | 53 (46–72) | 53.5 (36–79) | 47 (38–54) | 53 (36–79) | 15 (8–22) | 35 (25–47) |
Symptoms onset, months ago†| 72 (12–300) | 60 (24–312) | 108 (52–156) | 120 (36–420) | 75 (24–420) | nd ‡ |  |
Disease activity†§ | 2 (0–4)§ | 4.11 (2.46–4.61)§ | 4.18 (2.50–5,89)§ | 7,3 (4–10)§ |  | > 30 § |  |